Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional

COMO: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DME

ClinicalTrials.gov ID: NCT07449936

Public ClinicalTrials.gov record NCT07449936. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 4:28 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Multicenter, Prospective, Randomized, Double-Masked, Parallel-Group Study of EYP-1901, a Tyrosine Kinase Inhibitor (TKI), Compared to Aflibercept (2 mg) in Participants With Diabetic Macular Edema (DME)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a phase 3 randomized, double -masked study comparing the efficacy of EYP-1901 against Aflibercept.

Study identification

NCT ID
NCT07449936
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
EyePoint Pharmaceuticals, Inc.
Industry
Enrollment
240 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 16, 2026 (Actual)
Primary completion
Oct 2027 (Estimated)
Completion
Oct 2028 (Estimated)
Last update posted
Oct 2, 2026

2026 – 2028

United States locations

U.S. sites
53
U.S. states
23
U.S. cities
52
Facility City State ZIP Site status
California Retina Consultants Bakersfield California 93309 —
The Retina Partners Encino California 91436 —
Global Research Management, Inc. Glendale California 91204 —
Northern California Retina Vitreous Associates Medical Group INC. Mountain View California 94040 —
Retina Consultants of San Diego Poway California 92064 —
California Eye Specialists Medical Group, Inc. Redlands California 92373 —
Retinal Consultants Medical Group - Parkcenter Drive Sacramento California 95825 —
Retinal Consultants Medical Group Sacramento California 95841 —
Retina Consultants of Southern Colorado Colorado Springs Colorado 80909 —
Colorado Retina Associates Lakewood Colorado 80228 —
Advanced Research LLC Sibia Eye Institute Boynton Beach Florida 33437 —
Advance Medical Research Group, Inc Deerfield Beach Florida 33064 —
Eye Associates of Pinellas Pinellas Park Florida 33782 —
Retina Vitreous Associates of Florida - Saint Petersburg St. Petersburg Florida 33711 —
Southern Vitreoretinal Associates Tallahassee Florida 32308 —
Retina Specialists of Tampa Wesley Chapel Florida 33544 —
Georgia Retina Marietta Georgia 30060 —
Retina Consultants of Hawaii ‘Aiea Hawaii 96701 —
Red River Research Partners Plainfield Illinois 60586 —
Midwest Eye Institute - Carmel Carmel Indiana 11220 —
Haik Humble Eye Center West Monroe Louisiana 71291 —
Johns Hopkins Medicine - The Johns Hopkins Hospital Campus - Wilmer Eye Institute Baltimore Maryland 21287 —
Retina Group of Washington Chevy Chase Maryland 20815 —
Cumberland Valley Retina Consultants Hagerstown Maryland 21740 —
Retina Specialists - Towson Towson Maryland 21204 —
New England Retina Consultants Springfield Massachusetts 01107 —
Retina Associates of Michigan Grand Blanc Michigan 48439 —
Foundation for Vision Research Grand Rapids Michigan 49546 —
Sierra Eye Associates Reno Nevada 89502 —
NJRetina Care Center - Teaneck Teaneck New Jersey 07666 —
NJ Retina - Toms River Toms River New Jersey 08755 —
Retina Associates of Western New York Rochester New York 14620 —
VRCNY/Long Island Vitreoretinal Consultants Westbury New York 11590 —
Asheville Eye Associates - Regional Medical Park Asheville North Carolina 28803 —
Cape Fear Retinal Associates, PC Wilmington North Carolina 28401 —
Piedmont Retina Specialists, P.A. - Winston-Salem Office Winston-Salem North Carolina 27103 —
Tulsa Retina Consultant Tulsa Oklahoma 74114 —
Erie Retina Research Erie Pennsylvania 16507 —
Charleston Neuroscience Institute - Beaufort Beaufort South Carolina 29902 —
Retina Consultants of Carolina P.A Greenville South Carolina 29605 —
Tennessee Retina Nashville Tennessee 37203 —
Retina Research Institute of Texas Integrated Clinical Research Abilene Texas 79606 —
Texas Retina Associates Dallas Texas 75231 —
Mt. Olympus Medical Research Houston Texas 77479 —
Retina Consultants of Texas Katy Texas 77494 —
Texas Retina Associates Plano Texas 75075 —
Retina Consultants of Texas Schertz Texas 78154 —
Tyler Retina Consultants Tyler Texas 75703 —
Retina Associates of Utah Salt Lake City Utah 84107 —
Salt Lake Retina West Jordan Utah 84088 —
Piedmont Eye Center Lynchburg Virginia 24502 —
Virginia Retina Center Warrenton Virginia 20186 —
Northeast Wisconsin Retina Associates Appleton Wisconsin 54914 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 20 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07449936, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 2, 2026 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT07449936 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →